Cannabics Pharmaceuticals Inc
CNBX Pharmaceuticals Inc., a clinical-stage company, engages in the discovery, development, and commercialization of novel cannabinoid-based products and technologies for the treatment of cancer. Its lead product candidate is Cannabics SR, an oral capsule developed for the treatment of patients with advanced cancer and cancer anorexia cachexia syndrome. The company is also developing various drug… Read more
Cannabics Pharmaceuticals Inc (CNBX) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of November 2025: 0.018x
Based on the latest financial reports, Cannabics Pharmaceuticals Inc (CNBX) has a cash flow conversion efficiency ratio of 0.018x as of November 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-47.41K) by net assets ($-2.57 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cannabics Pharmaceuticals Inc - Cash Flow Conversion Efficiency Trend (2005–2025)
This chart illustrates how Cannabics Pharmaceuticals Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Cannabics Pharmaceuticals Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Cannabics Pharmaceuticals Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Anglesey Mining plc
F:4A0
|
-0.009x |
|
Upper Egypt Flour Mills
EGX:UEFM
|
N/A |
|
SASOL (SAOA.SG)
STU:SAOA
|
N/A |
|
Qlosr Group AB Series B
ST:QLOSR-B
|
-0.012x |
|
Archos
PA:ALJXR
|
-0.044x |
|
RABA (RMV1.SG)
STU:RMV1
|
0.144x |
|
Four Arrows Capital Corp
V:AROW-P
|
-0.006x |
|
Iljin Diamond Co. Ltd.
KQ:081000
|
N/A |
Annual Cash Flow Conversion Efficiency for Cannabics Pharmaceuticals Inc (2005–2025)
The table below shows the annual cash flow conversion efficiency of Cannabics Pharmaceuticals Inc from 2005 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-08-31 | $-2.50 Million | $-171.31K | 0.069x | -30.33% |
| 2024-08-31 | $-2.48 Million | $-244.27K | 0.098x | +76.59% |
| 2023-08-31 | $-2.02 Million | $-112.52K | 0.056x | -94.58% |
| 2022-08-31 | $-1.63 Million | $-1.68 Million | 1.029x | +174.52% |
| 2021-08-31 | $1.81 Million | $-2.49 Million | -1.380x | +12.22% |
| 2020-08-31 | $1.76 Million | $-2.77 Million | -1.573x | -649.48% |
| 2019-08-31 | $14.74 Million | $-3.09 Million | -0.210x | +71.89% |
| 2018-08-31 | $2.65 Million | $-1.97 Million | -0.746x | -154.00% |
| 2017-08-31 | $2.94 Million | $-863.57K | -0.294x | -214.37% |
| 2016-08-31 | $-467.45K | $-120.10K | 0.257x | -55.57% |
| 2015-08-31 | $-309.63K | $-179.06K | 0.578x | +1416.88% |
| 2014-08-31 | $4.45 Million | $-195.42K | -0.044x | -116.99% |
| 2013-08-31 | $-105.39K | $-27.25K | 0.259x | +158.42% |
| 2010-08-31 | $59.97K | $6.00K | 0.100x | -84.62% |
| 2009-08-31 | $-174.95K | $-113.82K | 0.651x | +2302.87% |
| 2008-08-31 | $289.87K | $-8.56K | -0.030x | +78.90% |
| 2006-08-31 | $144.45K | $-20.22K | -0.140x | +85.77% |
| 2005-08-31 | $-1.28K | $1.26K | -0.984x | -- |